专利 已申请

"COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND A METHOD FOR THE PROPHYLAXIS AND TREATMENT OF THE ADHESION PROCESS"

专利「"COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND A METHOD FOR THE PROPHYLAXIS AND TREATMENT OF THE ADHESION PROCESS"」由 JOINT STOCK COMPANY "PHARMASYNTEZ" 持有,当前状态为已申请,申请号 P/291。LaoBiz 老商通提供老挝知识产权信息检索与企业关联查询。

Patent “"COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND A METHOD FOR THE PROPHYLAXIS AND TREATMENT OF THE ADHESION PROCESS"” is held by JOINT STOCK COMPANY "PHARMASYNTEZ"; status: 已申请. Search Laos IP records on LaoBiz.

申请号 P/291
申请日期 2012-05-17
申请人 JOINT STOCK COMPANY "PHARMASYNTEZ"
代理机构 CONCETTI-LAO CO., LTD
类别 A61P 41/00 · C07D 401/04 · C08G 73/06 · C08L 79/06

图样

下载

基础信息

类型
专利
申请号
P/291
状态
已申请
申请人
JOINT STOCK COMPANY "PHARMASYNTEZ"
代理机构
CONCETTI-LAO CO., LTD
申请日期
2012-05-17
公开/公告日
2025-11-14
国际分类
A61P 41/00 · C07D 401/04 · C08G 73/06 · C08L 79/06
商品 / 服务

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查 进行中
  3. 实质审查
  4. 公开
  5. 授权

关联分析

LaoBiz 企业数据库联动

摘要

The invention relates to the field of pharmacy, clinical and experimental medicine and veterinary mcdicine, and in particular to novel inhibitory compounds of a p38 MAP kinase with a structure of the type (I)-(VIl) which can be used for the treatment or prophylaxis of adhesion. The invention discloses pharmaceutical compositions contain ing an effective amount of the substance SB203580 or one of the compounds of the type (I)-(VII) or a combination thereof and a pharmaceutically acceptable carrier, a diluent or an excipient. Also disclosed is the use of the substance SB203580 as an agent having anti-adhesion activity. Also disclosed is: a method for the prophylaxis and/or treatment of a disease or a condition in which there is the possibility of the formation and/or growth of adhesions which makes it possible to dispense with the additional administration of a preparation in the post-operative period

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种